- Home
- TNGX vs BRDG Comparison
TNGX vs BRDG Comparison
Compare TNGX & BRDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- BRDG
- Stock Information
- Founded
- TNGX 2014
- BRDG 2009
- Country
- TNGX United States
- BRDG United States
- Employees
- TNGX N/A
- BRDG N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- BRDG Investment Managers
- Sector
- TNGX Health Care
- BRDG Finance
- Exchange
- TNGX Nasdaq
- BRDG Nasdaq
- Market Cap
- TNGX 317.4M
- BRDG 323.7M
- IPO Year
- TNGX N/A
- BRDG 2021
- Fundamental
- Price
- TNGX $1.96
- BRDG $9.69
- Analyst Decision
- TNGX Strong Buy
- BRDG Hold
- Analyst Count
- TNGX 7
- BRDG 6
- Target Price
- TNGX $12.33
- BRDG $10.67
- AVG Volume (30 Days)
- TNGX 817.7K
- BRDG 654.5K
- Earning Date
- TNGX 05-07-2025
- BRDG 05-07-2025
- Dividend Yield
- TNGX N/A
- BRDG 4.88%
- EPS Growth
- TNGX N/A
- BRDG N/A
- EPS
- TNGX N/A
- BRDG 0.25
- Revenue
- TNGX $42,069,000.00
- BRDG $419,220,000.00
- Revenue This Year
- TNGX N/A
- BRDG N/A
- Revenue Next Year
- TNGX N/A
- BRDG $26.25
- P/E Ratio
- TNGX N/A
- BRDG $38.29
- Revenue Growth
- TNGX 15.17
- BRDG 61.35
- 52 Week Low
- TNGX $1.72
- BRDG $6.18
- 52 Week High
- TNGX $12.02
- BRDG $11.69
- Technical
- Relative Strength Index (RSI)
- TNGX 37.66
- BRDG 54.40
- Support Level
- TNGX $1.80
- BRDG $9.14
- Resistance Level
- TNGX $2.01
- BRDG $9.71
- Average True Range (ATR)
- TNGX 0.21
- BRDG 0.40
- MACD
- TNGX 0.01
- BRDG -0.08
- Stochastic Oscillator
- TNGX 31.94
- BRDG 34.17
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About BRDG Bridge Investment Group Holdings Inc.
Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its nationwide operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its broad range of products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The company operates Its business in a single segment, alternative investment management, diversified across specialized and synergistic investment platforms.